Home › Epilepsy › NCT06934356
Subcortical Arousal in Perceptual Awareness
Recruiting
Shared Subcortical Arousal Systems Across Perceptual Modalities
Who can join
Ages 13 and older · All sexes
Full eligibility criteria
A. The following are the inclusion/exclusion criteria for healthy participants age 18 years and up (Aim 1 and 2): Inclusion: (1) normal vision with or without the use of corrective lenses; (2) normal hearing not needing an assistive hearing device. Exclusion: (1) past history of diagnosis of a psychiatric or neurologic disease; (2) current psychiatric or neurologic disease; (3) requires hard contact lenses or glasses to maintain normal vision (prevents accurate pupil and eye gaze measurements); (4) pregnant or nonremovable ferrous metal objects inside or on the body (prevents MRI). B. The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 13 years and up (Aim 3A): Inclusion: (1) normal vision with or without the use of corrective lenses Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves. C. The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 18 year and up (Aim 3B): Inclusion: (1) normal vision with or without the use of corrective lenses; (2) A female subject must have a negative pregnancy test and if sexually active, must be using a reliable form of birth control for the duration of the trial, be surgically sterile, or be at least two years post-menopausal. Exclusion: (1) severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements); (2) unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves; (3) Pregnancy.
About the study
The study consists of prospective enrollment of healthy participants and patients with epilepsy, as well as analysis of an existing data set. Healthy participants will be studied with fMRI, eye metrics and behavioral testing at Yale. Patients will be studied with intracranial thalamic and cortical recording and stimulation, eye metrics and behavioral testing.
What is being tested
- EEG (device)
- Eye Tracking (device)
- Behavioral task (device)
- fMRI (diagnostic test)
Sponsor: Yale University · Participants: 202 · Started: Oct 13, 2025
Contact the study team
- Hal Blumenfeld, MD, PHD · Phone: (203) 785-3865
Official record on ClinicalTrials.gov — NCT06934356
Locations in the U.S.
| Connecticut | Yale School of Medicine, New Haven |
| Kansas | University of Kansas Medical Center, Kansas City |
| Massachusetts | Massachusetts General Hospital, Boston |
| Minnesota | Mayo Clinic, Rochester |
| New Hampshire | Dartmouth Hitchcock Medical Center, Lebanon |
| Pennsylvania | University of Pittsburgh Medical Center, Pittsburgh (Not yet recruiting) |
| Tennessee | Vanderbilt University Medical Center, Nashville |
| Texas | Baylor College of Medicine, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.